PSYCHEMEDICS CORP

PSYCHEMEDICS CORP (ticker: PMDI) is an OTC-listed services-medical laboratories company. DredgeCap's structured extraction of PMDI's SEC filings surfaces 6 active risk signals, including 3 delisting/deregistration signals, 2 late-filing signals, and 1 auditor-change signal. PMDI reported $32.74M in revenue and -$1.86M for the period ending 2018-09-30, with operating cash flow of $929K. Cash and equivalents stood at $1.42M (down 27.9% year-over-year). Total assets of $8.32M exceed total liabilities of $3.19M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

PMDI Cash Runway

Months-of-runway analysis for PMDI, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on PMDI

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.